ALX Oncology Receives U.S. FDA Orphan Drug Designation for Evorpacept for the Treatment of Patients with Gastric Cancer and Gastroesophageal Junction Cancer

3 years ago

SOUTH SAN FRANCISCO, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage…

Quipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results

3 years ago

POSTS REVENUE GROWTH OF 41% AND ADJUSTED EBITDA GROWTH OF 38% SURPASSING PRELIMINARY GUIDANCE STRONG ORGANIC GROWTH OF 10% AS…

Trinity Biotech Announces The Successful Closing of its Debt Refinancing

3 years ago

DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic…

Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus

3 years ago

MELBOURNE, Australia and ATHENS, Greece, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…

Applied Molecular Transport Announces Board Appointments

3 years ago

John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair…

Globus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call

3 years ago

AUDUBON, Pa., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its…

CooperCompanies Announces Release Date for First Quarter 2022

3 years ago

SAN RAMON, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release first quarter 2022…

Vaccinex Announces $6.6 Million Private Placement

3 years ago

Participants include a syndicate of existing and new shareholdersContributes to total of $10.1 million in new equity financing for January,…

Stryker reports 2021 operating results and 2022 outlook

3 years ago

Kalamazoo, Michigan, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year…

23andMe to Report FY2022 Third Quarter Financial Results

3 years ago

SUNNYVALE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research…